GSK-3 Inhibitors: Anti-Diabetic Treatment Associated with Cardiac Risk? : Editorial to: "The Impact of Chronic Glycogen Synthase Kinase-3 Inhibition on Remodeling of Normal and Pre-Diabetic Rat Hearts." by Barbara Huisamen et al.
Department of Genetics & Cell Biology, CARIM School for Cardiovascular Diseases, Maastricht University, P.O. Box 616, 6200, MD, Maastricht, the Netherlands. m.nabben@maastrichtuniversity.nl.
Miranda
M
Nabben
Department of Genetics & Cell Biology, CARIM School for Cardiovascular Diseases, Maastricht University, P.O. Box 616, 6200, MD, Maastricht, the Netherlands.
Dietbert
D
Neumann
D000818:Animals; D004791:Enzyme Inhibitors; D038362:Glycogen Synthase Kinase 3 / Q000037:antagonists & inhibitors*; D006321:Heart; D009206:Myocardium; D010766:Phosphorylation; D051381:Rats
D004791:Enzyme Inhibitors; D038362:Glycogen Synthase Kinase 3